CorMedix Inc.
CRMD
$6.38
$0.010.16%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 23.34% | 162.41% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 23.34% | 162.41% | |||
| Cost of Revenue | 47.60% | 306.26% | |||
| Gross Profit | 21.44% | 155.34% | |||
| SG&A Expenses | -19.80% | 130.59% | |||
| Depreciation & Amortization | 179.44% | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.02% | 162.11% | |||
| Operating Income | 35.02% | 162.73% | |||
| Income Before Tax | 7.36% | 158.37% | |||
| Income Tax Expenses | 175.78% | -10,835.72% | |||
| Earnings from Continuing Operations | -87.09% | 447.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -87.09% | 447.52% | |||
| EBIT | 35.02% | 162.73% | |||
| EBITDA | 44.66% | 179.79% | |||
| EPS Basic | -88.44% | 389.83% | |||
| Normalized Basic EPS | 27.09% | 128.15% | |||
| EPS Diluted | -87.54% | 350.00% | |||
| Normalized Diluted EPS | 21.16% | 112.73% | |||
| Average Basic Shares Outstanding | 3.83% | 11.78% | |||
| Average Diluted Shares Outstanding | 8.94% | 19.88% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||